Posts in category

In Depth


What advice can pharmacists give when discussing dental injuries? Alex Park takes a look Dental injuries can happen during sport, falls, play or everyday accidents. A patient or parent may …

Australia’s pharmacy network has repeatedly shown its capacity to evolve to meet the needs of the community and could provide a platform for fixed-site drug-checking services The expansion of pill …

Debbie Rigby rounds up the latest in research news Risk factors for cardiovascular mortality in patients with obstructive sleep apnoea Obstructive sleep apnoea (OSA) is associated with increased cardiovascular mortality. …

With growing demand for pharmacists to deliver new services, owners looking to fill vacancies in their teams might consider sourcing candidates from the UK, writes LocumCo founder, Sue Muller Australia’s …

It’s November 1926, and the formation of a national pharmacy guild or union appears to be off the table With the Pharmacy Guild of Australia set to celebrate its centenary …

Debbie Rigby rounds up the latest in research news Macrolides for asthma A systematic review and meta-analysis of randomized trials has concluded that macrolides likely reduce severe exacerbations and improve …

When should deprescribing medicines for glaucoma be considered? Amy Page and Amanda Quek take a look  Deprescribing is defined as a person-centred process of medication withdrawal intended to achieve improved …

“Whether we like it or not we cannot escape some degree of involvement in world trends,” we wrote in 1966 It’s November 1966, and there’s tension between Australia’s state pharmacy …

Whether it’s persistent dry eye, styes, conjunctivitis or medicine-related visual changes, pharmacists play an important role in knowing when to treat, when to investigate and when to refer.  KEY POINTS: …

Dr Alex Park investigates common causes of oral health problems in older people, including the use of medicines Poor oral health is common in older people, but it should not …

Debbie Rigby rounds up the latest research news Comparative cardiorenal efficacy and safety of SGLT2 inhibitors and finerenone in chronic kidney disease with type 2 diabetes SGLT2 inhibitors and finerenone …

Osteoporosis remains underdiagnosed, and opportunities to prevent first and future fractures are being missed. We explore how pharmacists can help identify risk earlier, keep treatment on track and reduce falls …